-
1 Comment
Bio-Rad Laboratories, Inc is currently in a long term uptrend where the price is trading 13.5% above its 200 day moving average.
From a valuation standpoint, the stock is 99.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 7.0.
Bio-Rad Laboratories, Inc's total revenue rose by 26.5% to $790M since the same quarter in the previous year.
Its net income has increased by 51.6% to $839M since the same quarter in the previous year.
Finally, its free cash flow grew by 77.6% to $245M since the same quarter in the previous year.
Based on the above factors, Bio-Rad Laboratories, Inc gets an overall score of 5/5.
Industry | Medical Devices |
---|---|
Sector | Healthcare |
Exchange | NYSE |
CurrencyCode | USD |
ISIN | US0905722072 |
Market Cap | 7B |
---|---|
PE Ratio | None |
Target Price | 353.1667 |
Beta | 1.12 |
Dividend Yield | None |
Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials, such as cells, proteins, and nucleic acids used in biopharmaceutical manufacturing, quality control process, food safety, and science education applications. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, and transfusion and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for BIO using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025